Affiliations
- 1Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore.
- 2Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore, 169857, Singapore.
- 3Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, 308232, Singapore.
- 4SingHealth Duke-NUS Institute of Precision Medicine, Singapore, 169609, Singapore.
- 5Genome Research Informatics & Data Science Platform, Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, 138672, Singapore.
- 6Saw Swee Hock School of Public Health, National University of Singapore, Singapore, 117549, Singapore.
- 7Department of Obstetrics & Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.
- 8Singapore Institute for Clinical Sciences, Singapore, 117609, Singapore.
- 9Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, Singapore, 169857, Singapore.
- 10SingHealth Duke-NUS Genomic Medicine Centre, Singapore, 168582, Singapore.
- 11Personalized Medicine Service, Tan Tock Seng Hospital, Singapore, 308433, Singapore.
- 12National Healthcare Group Polyclinics, Singapore, 138543, Singapore.
- 13Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, 138672, Singapore.
- 14Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, 168751, Singapore.
- 15Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, 138672, Singapore.
- 16Human Genomics, Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, 138672, Singapore.
- 17Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.
- 18Ophthalmology & Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore, 169857, Singapore.
- 19Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, 138671, Singapore.
- 20Human Development, Singapore Institute for Clinical Sciences, Singapore, 117609, Singapore.
- 21Clinical Data Engagement, Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, 138671, Singapore.
- 22Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117596, Singapore.
- 23Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, 308433, Singapore.
- 24Department of Cardiology, National Heart Centre Singapore, Singapore, 169609, Singapore.
- 25Duke-NUS Medical School, Singapore, 169857, Singapore.
- 26Precision Health Research Singapore (PRECISE), Singapore, 139234, Singapore.
- 27Department of Epidemiology and Biostatistics, Imperial College London, London, W2 1PG, UK.
- 28SingHealth Duke-NUS Institute of Precision Medicine, Singapore, 169609, Singapore. patrick.tan@precise.cris.sg.
- 29Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, 138672, Singapore. patrick.tan@precise.cris.sg.
- 30Precision Health Research Singapore (PRECISE), Singapore, 139234, Singapore. patrick.tan@precise.cris.sg.
- 31Cancer & Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore. patrick.tan@precise.cris.sg.
- 32Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. patrick.tan@precise.cris.sg.
- 33SingHealth Duke-NUS Institute of Precision Medicine, Singapore, 169609, Singapore. Saumya.S.Jamuar@singhealth.com.sg.
- 34SingHealth Duke-NUS Genomic Medicine Centre, Singapore, 168582, Singapore. Saumya.S.Jamuar@singhealth.com.sg.
- 35Genetics Service, Department of Paediatrics, KK Women’s and Children’s Hospital, Singapore, 229899, Singapore. Saumya.S.Jamuar@singhealth.com.sg.
- 36Paediatric Academic Clinical Program, Duke-NUS Medical School, Singapore, 169857, Singapore. Saumya.S.Jamuar@singhealth.com.sg.
- 37Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore. joanne.ngeow@ntu.edu.sg.
- 38Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore, 169857, Singapore. joanne.ngeow@ntu.edu.sg.
- 39Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, 308232, Singapore. joanne.ngeow@ntu.edu.sg.
- 40Institute of Molecular and Cellular Biology, Agency for Science, Technology and Research, Singapore, 138673, Singapore. joanne.ngeow@ntu.edu.sg.
- 41SingHealth Duke-NUS Institute of Precision Medicine, Singapore, 169609, Singapore. wengkhong.lim@duke-nus.edu.sg.
- 42SingHealth Duke-NUS Genomic Medicine Centre, Singapore, 168582, Singapore. wengkhong.lim@duke-nus.edu.sg.
- 43Cancer & Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore. wengkhong.lim@duke-nus.edu.sg.
Abstract
Asian populations are under-represented in human genomics research. Here, we characterize clinically significant genetic variation in 9051 genomes representing East Asian, South Asian, and severely under-represented Austronesian-speaking Southeast Asian ancestries. We observe disparate genetic risk burden attributable to ancestry-specific recurrent variants and identify individuals with variants specific to ancestries discordant to their self-reported ethnicity, mostly due to cryptic admixture. About 27% of severe recessive disorder genes with appreciable carrier frequencies in Asians are missed by carrier screening panels, and we estimate 0.5% Asian couples at-risk of having an affected child. Prevalence of medically-actionable variant carriers is 3.4% and a further 1.6% harbour variants with potential for pathogenic classification upon additional clinical/experimental evidence. We profile 23 pharmacogenes with high-confidence gene-drug associations and find 22.4% of Asians at-risk of Centers for Disease Control and Prevention Tier 1 genetic conditions concurrently harbour pharmacogenetic variants with actionable phenotypes, highlighting the benefits of pre-emptive pharmacogenomics. Our findings illuminate the diversity in genetic disease epidemiology and opportunities for precision medicine for a large, diverse Asian population.
PMID: 36335097 DOI: 10.1038/s41467-022-34116-9